financetom
Business
financetom
/
Business
/
NXP Semiconductors Insider Sold Shares Worth $2,100,360, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
NXP Semiconductors Insider Sold Shares Worth $2,100,360, According to a Recent SEC Filing
Jul 7, 2025 12:33 AM

03:20 AM EDT, 07/07/2025 (MT Newswires) -- Jennifer Wuamett, Executive Vice President & General Counsel, on July 02, 2025, sold 9,132 shares in NXP Semiconductors ( NXPI ) for $2,100,360. Following the Form 4 filing with the SEC, Wuamett has control over a total of 27,088 common shares of the company, with 27,088 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1413447/000141344725000100/xslF345X05/wk-form4_1751581174.xml

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Why Tenon Medical (TNON) Stock Is Skyrocketing Friday
Why Tenon Medical (TNON) Stock Is Skyrocketing Friday
Sep 20, 2024
Tenon Medical Inc ( TNON ) shares are trading higher by 21.3% to $6.10 during Friday’s session after the company announced the issuance of three notices of allowance for patent applications from the UPSTO. What To Know: These patents cover innovations related to SI joint prostheses, including drug delivery systems that aids bone growth and new designs to address failed...
US FDA approves Zevra's genetic disorder treatment
US FDA approves Zevra's genetic disorder treatment
Sep 20, 2024
Sept 20 (Reuters) - The U.S. Food and Drug Administration approved Zevra Therapeutics' ( ZVRA ) drug for a rare and fatal genetic disorder, the first treatment to get a nod for the condition, the health regulator said on Friday. (Reporting by Sriparna Roy and Kashish Tandon in Bengaluru; Editing by Devika Syamnath) ...
Market Chatter: Tech Giants Seek More Lenient AI Regulations in EU
Market Chatter: Tech Giants Seek More Lenient AI Regulations in EU
Sep 20, 2024
10:26 AM EDT, 09/20/2024 (MT Newswires) -- Major technology firms are pushing for a more lenient approach to artificial intelligence regulations in the European Union ahead of the AI Act's enforcement, Reuters reported Friday. While the AI Act was passed in May, the level of enforcement would depend on the law's accompanying code of practice, which has not been finalized,...
US FDA approves Zevra's treatment for rare genetic disease
US FDA approves Zevra's treatment for rare genetic disease
Sep 20, 2024
(Reuters) -The U.S. Food and Drug Administration approved Zevra Therapeutics' ( ZVRA ) drug for a rare and fatal genetic disorder, making it the first treatment to get a nod for the condition, the health regulator said on Friday. The company has been trying for years to bring the drug to market after the U.S. health regulator previously declined to...
Copyright 2023-2026 - www.financetom.com All Rights Reserved